Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
The medical director of a Denver eating disorder clinic says popular medications that are being used as weight loss drugs are ...
State DHS officials say new weight-loss drugs are driving up costs for Pennsylvania’s Medicaid program, likely leading to ...
The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...